Allergan
Most Read
Pharmalot, Pharmalittle: Mylan CEO to testify about EpiPen before Congress next week
Allergan CEO looks smart for pledging to rein in prices. But will it make a difference?
Q&A: Allergan’s CEO speaks out on limiting drug prices. ‘Somebody had to take the first step’
Allergan CEO promises to limit price hikes on drugs in a bid to rebuild the ‘social contract’
Pharmalot, Pharmalittle: Biogen is the latest pharma takeover target
To split or not to split? One Wall Street wag thinks Pfizer may remain intact
Former drug company executive is acquitted of hatching a kickback scheme
All Coverage
advertisement
